Petros Pharmaceuticals, Inc. Operating Lease Right-of-Use Assets
Petros Pharmaceuticals, Inc. (PTPI) had Operating Lease Right-of-Use Assets of $113.73 thousand as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-03-31
- 2024-12-31: Operating Lease, Right-of-Use Asset $113.73K.
- 2024-09-30: Operating Lease, Right-of-Use Asset $124.93K.
- 2024-06-30: Operating Lease, Right-of-Use Asset $153.74K.
- 2024-03-31: Operating Lease, Right-of-Use Asset $190.57K.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2024-12-31 | $113.73K 10-K · filed 2025-03-31 | |
| 2024-09-30 | $124.93K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $153.74K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $190.57K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $226.26K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $260.85K 10-Q · filed 2023-11-15 | |
| 2023-06-30 | $294.39K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $326.92K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $358.47K 10-K · filed 2024-04-01 | $358.47K 10-K · filed 2023-03-31 |
| 2022-09-30 | $389.08K 10-Q/A · filed 2022-11-15 | |
| 2022-06-30 | $418.78K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $447.60K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $475.56K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $502.70K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $529.06K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $554.38K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $579.53K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |